Di seguito l'elenco completo dei nostri comunicati stampa (pagina 1 di 28):
Chronic disease drugs fueling Indian pharma boom! Industry to see double-digit growth with new product launches.
A study reveals nearly 2 million people in England and Scotland suffer from long COVID, impacting daily activities and workforce participation.
AbbVie & Gilgamesh join forces to develop neuroplasticity-based treatments for mood & anxiety disorders.
Infinity Labs doubles down on quality! ISO certification ensures excellence in chemical & microbiological testing.
India's Bharat Biotech & Bilthoven team up to ensure reliable supply of Oral Polio Vaccine (OPV) worldwide.
Breakthrough in liver disease treatment! New collaboration focuses on regenerative therapies for chronic liver disease.
The FDA warned Cardinal Health for distributing unapproved Chinese syringes under the Monoject brand, citing risks to medical device safety and compliance.
Catalent plans to lay off 130 employees in Bloomington, Indiana, as part of its restructuring, despite a $16.5B acquisition offer from Novo Holdings.
Zydus Lifesciences secures US FDA approval for Dapsone Gel 7.5%. An effective acne treatment, it targets bacterial growth and inflammation.
Charles River demonstrates its commitment to environmental responsibility through investments and partnerships.
Cresset establishes its new India headquarters in Bangalore to serve the expanding market for computational drug discovery solutions in Asia Pacific.
NHS patients with PAH to benefit from cutting-edge digital technology - personalized care for a life-threatening condition.
DP007 - a new hope for respiratory patients and the planet! Lowers global warming potential compared to current inhalers.
FDA approves Roche's Lp(a) test - a game-changer for identifying patients who can benefit from innovative cholesterol-lowering treatment.
A child in Ontario has died of measles, marking the first such death in a decade. The child was unvaccinated, highlighting concerns about vaccine hesitancy.
Funding boost for Grey Wolf Therapeutics' innovative approach to fighting cancer and autoimmune diseases.
GSK's depekomab targets eosinophilic asthma, offering new hope for millions struggling with severe asthma.
AstraZeneca admits rare thrombosis with thrombocytopenia syndrome (TTS) risk in its COVID-19 vaccine. Legal acknowledgment may lead to settlements.
Eli Lilly expands Indiana plant with a $9 billion investment, creating hundreds of new jobs and boosting production of key diabetes and obesity drugs.
New technology slashes cell therapy production costs by automating the process, paving the way for wider access.
Nestle introduces Vital Pursuit, a $5 line of frozen pizzas and protein pasta for people on weight-loss drugs Wegovy and Ozempic, packed with nutrients.
NIBRT launched a new advanced therapies facility in Dublin, expanding research and training for innovative biomedicines like gene therapies and vaccines.
Novartis invests $256M in Singapore to expand antibody drug manufacturing, boost efficiency with digital tech, and create 100 skilled jobs.
The global pharmaceutical chemicals market is projected to grow at a CAGR of 4.9%, reaching $278.76 billion by 2029, driven by demand for novel medicines and contract manufacturing.
India’s pharmaceutical sector sees Rs 28,328 crore investment under PLI scheme, with significant growth in bulk drugs and medical devices.
Don't miss Pharma Now's latest offerings! Explore innovations & resources at the PharmaLabChem Expo.
Recce Pharmaceuticals ramps up production of new synthetic antibiotic to combat global health threat.
Promising results from Zerion Pharma's Dispersome® technology suggest it could improve existing cystic fibrosis treatments.
Sartorius and TheWell Bioscience join forces to develop innovative 3D cell models, potentially revolutionizing drug testing.
Schreiner MediPharm's innovative service tailors RFID labels on demand, reducing costs and boosting pharmaceutical supply chain efficiency.
Shweta Munjal becomes Chief Communication & CSR Officer at Glenmark Pharmaceuticals, bringing 20+ years of leadership in communications, marketing, and CSR.
South Korea faces a worsening doctor shortage in small cities, amplified by a 3-month trainee doctor strike against policies to boost medical school admissions.
Strides Pharma’s subsidiary gets USFDA approval for generic Sucralfate Oral Suspension, 1gm/10ml, for treating ulcers and GERD, with a market size of USD 124M.
Sun Pharma acquires the remaining 21.52% of Taro Pharmaceuticals for ₹2,891.76 crore, completing the merger, and Taro's shares will be delisted from NYSE.
Sygnature Discovery earns EcoVadis Bronze rating, placing in the top 35% globally for environmental, social, and ethical performance in the life sciences sector.
Learn about TekniPlex Healthcare's participation in The Pharma Days event, where they will showcase their range of sustainable blister packaging solutions.
The U.S. proposes reclassifying marijuana to Schedule 3 to promote research, easing restrictions for cannabis companies, and enabling stock exchange listings.
Thermo Fisher is to lay off 74 employees at its Carlsbad plasmid DNA facility by May 31, 2024, citing demand fluctuations, per a WARN Act report.
Torbay Pharma appoints new COO and CPO to boost growth in North America, addressing supply chain challenges and rising demand for essential medicines.
TriLink BioTechnologies teams up with Johns Hopkins University to accelerate RNA therapeutics research with CleanScript.
Bayer concludes its joint venture with Zydus Lifesciences, acquiring full ownership of Bayer Zydus Pharma Private Ltd.
UPS Healthcare opens a new logistics facility in Dublin, providing end-to-end solutions and creating 30 new jobs.
New FDA regulations enforce stringent oversight of Laboratory Developed Tests to ensure their safety and effectiveness.
New clinical trial reveals promising outcomes for a personalised liver cancer vaccine, showing significant tumour regression.
Register for the “Sterility Testing in Pharmaceuticals” webinar by MicroVerse on June 9, 2024, featuring expert insights and networking.
British pharmacies cut prices on weight-loss treatments Wegovy and Mounjaro amid high demand and competitive market dynamics.
The World Bank Group commits to extending affordable healthcare access to 1.5 billion individuals by 2030 through innovative strategies and partnerships.
Novo Nordisk's weight-loss drug Wegovy shows promise for obese individuals with specific genetic profiles, aiding targeted weight loss.
Torrent Pharma tackles heartburn! Launches Kabvie, a new drug for GERD in India. Expected to be a game-changer for millions.
Confused about Biosimilars? Get the facts on how they offer same benefits as biologics at a fraction of the cost.
Orano Med's new lab to produce 100,000 lead-212 doses annually, offering a powerful new weapon against cancer.
FDA inspection finds major issues at Hengrui's China facility. Contamination control, cleaning & documentation flagged.
Vetter is expanding its U.S. and Germany operations, moving its facility to Des Plaines, and investing in Saarlouis, creating 2,000 jobs by 2030.
Big news in gut health! Nestlé acquires VOWST, a promising therapy to prevent C. Diff recurrence, expanding its reach in microbiome treatment.
The Pharma Packaging market is on fire! A new report predicts a surge to over $15 billion by 2032, driven by sustainability & automation.
GSK's Blenrep, combined with pomalidomide and dexamethasone, significantly reduces multiple myeloma progression risk by 50%
Wockhardt UK steps up! Secures £20 million funding to modernize facilities & expand vaccine production. Read more about their plans here.
Healthcare logistics on the rise! Market expected to surge by $121 billion by 2028, driven by pharma sales & cold chain advancements.
how BioXcel Therapeutics' AI platform accelerates drug development and promotes sustainability through efficient drug repurposing.
Schneider Electric takes center stage at ACHEMA 2024! EcoStruxure for Life Sciences promises to revolutionize sustainable pharma manufacturing.
Syntegon ups its game! Global leader acquires Telstar, boosting liquid pharma processing & freeze-drying solutions. Read the full story here.
FDA approves trials for Lomonitinib - a promising new drug for FLT3-mutated AML. Learn more about this potential breakthrough.
Cash Offer Alert! Cycle Pharmaceuticals steps up with an $8 per share bid to acquire Vanda. See how this could impact the rare disease market.
Syntegon's new Settle Plate Changer at Achema 2024 revolutionizes aseptic processing with enhanced automation and compliance.
Discover Antares Vision Group's HR600 PHC at ACHEMA 2024, showcasing milligram-level precision and autonomous error detection for ultimate quality control.
TurboFil Packaging Machines and Amneal Pharmaceuticals are partnering to create an automated naloxone vial assembly and filling machine.
Discover survodutide, a dual GLP-1 and glucagon agonist, showing promise in treating fibrosis and obesity with positive trial results.
NRx Pharmaceuticals advances next-gen ketamine therapy for severe depression, offering rapid, safe relief for treatment-resistant mental health disorders.
Explore the $1.6 billion partnership formed between Ipsen and Marengo in 2022 to advance precision immuno-oncology candidates from Marengo’s STAR platform.
Discover the groundbreaking partnership between Incepta Pharmaceuticals and MCRI to combat rotavirus infections in children.
BioXcel Therapeutics uses AI to accelerate drug development, focusing on sustainability and cost-effective drug repurposing.
Recce Pharmaceuticals completes dosing in Phase I/II UTI/Urosepsis trial of RECCE® 327, with data review by an Independent Safety Committee pending.
Lupin partners with OLIC Limited to distribute Nextstellis oral contraceptives in Vietnam and the Philippines, enhancing Lupin's women's health portfolio.
IPA's 9th Global Pharmaceutical Quality Summit in Mumbai on June 27-28 will focus on 'Advances in Manufacturing and Quality – Patient Centricity.'
Biocon appoints Mukesh Kamath as Interim CFO starting June 11, 2024. Kamath brings extensive finance experience from his 20-year tenure at Biocon.
ACG partners with EY-Parthenon to achieve net zero emissions and comply with the EU's CBAM, focusing on sustainability and carbon footprint reduction.
The YpsoMate 1.0 autoinjector simplifies methotrexate injections with a two-step process, safety features, and an ergonomic design for easy, secure use.
94% of pharma execs adapt revenue management for regulatory changes. CMS delays rule on aggregating discounts, seen as positive by Model N's Mendelsohn.
Evotec advances in neuroscience with Bristol Myers Squibb, earning $20M. Pre-clinical progress boosts neurodegenerative disease pipeline.
Delhi-based pharmaceutical firm in talks with PE firms for joint bid on BSV. Mankind Pharma plans fundraising for acquisitions and growth.
Dr. Reddy's secures exclusive US rights for Cyclophosphamide injection from Ingenus Pharmaceuticals, sharing 50% of profits.
Torrent Pharma's Indrad plant faces compliance scrutiny with a Form 483 from USFDA, citing five observations post-inspection.
Krista McKerracher, new Chairperson at Genialis, drives RNA-based biomarkers for personalized medicine, focusing on global patient outcomes in biopharma.
Borealis has appointed Stefan Doboczky as chief executive. His previous leadership roles and the priorities he inherits at the polyolefins and chemicals group.
EU Antitrust regulators charged Alchem International with price-fixing in a cartel for SNBB, risking fines up to 10% of global turnover.
BioCina secures exclusive rights to CelluTx's RBPS tech for efficient mcDNA production, enhancing gene therapies and biologics manufacturing.
ABIONYX Pharma completes pre-IND meeting with FDA, plans IND filing for apoA-I-based drug, advancing treatments for sepsis and critical care.
AbbVie and FutureGen collaborate on FG-M701, a promising TL1A antibody for IBD, with a $1.56 billion potential milestone and royalties deal.
The BreAK-CRC study tests STC-1010 cancer vaccine in advanced colorectal cancer across 9 EU/US centers, aiming for improved outcomes in cold tumors.
Suven Pharma to acquire 67.5% of Sapala Organics for Rs 229.5 crore, boosting nucleic acid therapy and ADC technology capabilities.
Takeda and Ascentage partner for global rights (ex-China/Russia/Taiwan/Macau/HK) to olverembatinib, a CML TKI, with $100M option payment and milestones.
Mankind Pharma's #RippleOfChange campaign promotes life-saving blood donations in India on World Blood Donor Day.
Sun Pharma and Moebius Medical's MM-II offers durable knee OA pain relief, paving the way for Phase 3 trials and EU approval.
Lupin's Nagpur facility passes USFDA inspection with no observations, ensuring high-quality standards upheld globally.
Wacker's new mRNA centre in Halle boosts vaccine production capacity, enhancing pandemic preparedness globally
Takeda plans potential $1.3B acquisition of Ascentage Pharma's innovative CML treatment olverembatinib
Enveda Biosciences raises $55M, totaling $119M in Series B funding, to advance AI-driven drug discovery and clinical trials for novel therapies by 2025.
Jagsonpal Pharmaceuticals has revealed that it has acquired businesses of Yash Pharma in India and Bhutan. Read the full news here!
DHL Enhances Pharma Logistics In France, Which Will Ultimately Result In Driving Innovation in Healthcare Supply Chain.
Discover the latest findings on RADICAVA® for ALS presented by Mitsubishi Tanabe Pharma at ENCALS 2024. Learn about new insights and study results.
Johnson & Johnson faces a $150M verdict over allegations of breaching marketing practices for HIV medications, intensifying legal battles.
Elion receives $81M funding to advance antifungal therapy, accelerating development and innovation in treatments.
Fosun Pharma to divest a 5% stake in Gland Pharma, raising $172 million in the transaction. This move is part of Fosun Pharma's strategic portfolio adjustment.
ALPLA Group expands its pharma packaging prowess with the acquisition of Heinlein Plastik-Technik GmbH, improving innovation in pharma packaging solutions.
Alembic Pharma achieves significant milestone as U.S. FDA approves Dabigatran Etexilate Capsules, signalling a breakthrough in pharmaceutical innovation.
Ascidian Therapeutics and Roche partner to advance medical research, aiming for breakthroughs in future treatments, shaping the future of medicine together.
Discover MilliporeSigma's €62M state-of-the-art quality control facility in Germany, setting new standards in life sciences innovation and efficiency.
Indian pharma giant Cipla invests EUR 3 million in German biotech firm Ethris, boosting innovative research and development in mRNA-based therapies.
Thermo Fisher's new clinical research hub in Wisconsin, advancing innovation and healthcare solutions. Read the whole news here!
Alvotech partners with Advanz Pharma to distribute AVT06 and AVT29, biosimilars of Eylea, enhancing access to eye disease treatments across Europe.
Belharra Therapeutic’s strategic alliance with Sanofi, aimed at advancing small molecule treatments for immunological disorders.
FDA approves Pryos Pharmaceuticals' Vigafyde, a new vigabatrin oral solution for infantile spasms in children, marking first new formulation in 15 years.
PCI Pharma Services signs a 25-year lease for an 82,000 sq ft facility in Stamullen, enhancing production and sustainability by Q1 2025.
Corealis Pharma expanded $10M facilities in Laval, boosting R&D and production capabilities, aiming to become a global leader in oral solid dosage formulations.
Zydus Lifesciences defends Biotax 1gm amid Nepal's quality concerns, asserting compliance with standards. Details on Business Standard.
AstraZeneca's Truqap, combined with paclitaxel, failed to meet primary endpoints in a trial for metastatic triple-negative breast cancer.
FDA issues warning letter citing violations in cGMP regulations at Sun Pharma's Dadra unit, impacting stock.
Kotak Alt invests Rs. 1,445 crore in Matrix Pharma’s API business, making it the 2nd largest ARV API player in India, expanding global collaborations.
Sun Pharma partners with Takeda to launch Voltapraz (Vonoprazan) in India, offering innovative treatment for reflux esophagitis and acid-related disorders.
Bora Pharmaceuticals expands its capabilities with the acquisition of Emergent BioSolutions’ sterile manufacturing plant in Baltimore-Camden, Maryland.
Discover Zealand Pharma's Phase 1b trial results on petrelintide for weight management. Learn more about this innovative biotechnology advancement today.
Pharma leader wins major international tenders for vital antibiotics and oncology drugs, enhancing global healthcare and boosting India's export influence.
The European Commission approves Takeda's FRUZAQLA for metastatic colorectal cancer, offering a new, effective treatment option for advanced-stage patients.
Abzena and Argonaut team up to enhance biopharmaceutical development, offering integrated solutions for faster, efficient therapy delivery
Sanofi and Biovac announce a collaboration to localize inactivated polio vaccine (IPV) production in Africa for 40+ countries, bolstering vaccine access and regional capacity.
GL0034, Sun Pharma's latest drug for obesity treatment, demonstrates significant weight loss and improved metabolic health in Phase 1 trials.
Lupin’s New Jersey facility earns a positive FDA report, enhancing its compliance reputation in the pharmaceutical industry.
Phio Pharmaceuticals secures a South Korean patent for RXI-185, targeting UV-induced aging and enhancing its skin care and cancer treatment portfolio.
FDA initiates surprise inspection at Sun Pharma's Mohali plant after finding manufacturing violations at Halol site.
Biocon Biologics gets EMA nod to produce Bevacizumab in Bengaluru, renews GMP certifications for facilities in India & Malaysia, ensuring top-quality standards.
Teva Pharmaceuticals to acquire Labrys Biologics for over $800M, expanding its migraine treatment lineup with promising drug LBR-101.
KDDF funds CHA Biotech's CBT101 R&D for two years, advancing NK cell therapy for recurrent glioblastoma to phase 2 trials and aiming for IND approval.
Lupin and Aurobindo Pharma recall products from the US market due to FDA alerts on manufacturing issues.
Biocon's API facility in Visakhapatnam, Andhra Pradesh, receives four observations from US FDA following inspection. Read more on the regulatory update.
Bharat Biotech includes ICMR as co-owner of Covid-19 vaccine patent, affirming commitment to collaboration and timely vaccine development.
Discover GSK's latest milestone, Omjjara (momelotinib) approved by Japan's MHLW for myelofibrosis treatment, offering hope to patients worldwide.
GSK's application to expand Jemperli with chemotherapy for all advanced or recurrent endometrial cancer patients is accepted by EMA.
Novo Nordisk announces a $4.1 billion investment in Clayton, NC, doubling production capacity for injectable treatments, creating 1,000 jobs.
Xellia's latest layoffs follow the sale of its assets to Hikma, impacting roles at its Bedford facility in the U.S.
ANI acquires Alimera, advancing their Rare Disease portfolio in ophthalmology. Expect enhanced patient care and strategic synergies.
Wacker and CordenPharma enter pandemic-ready state, poised to produce 80 million vaccine doses annually in response to future outbreaks. Learn more.
Silence Therapeutics receives a $2M milestone payment from Hansoh Pharma, advancing their mRNAi GOLD platform to tackle genetic diseases.
ProBio Inc. launches a new 128,000 sq ft facility in Hopewell, NJ, boosting plasmid DNA and viral vector production for cell and gene therapy in North America.
Parse Biosciences partners with Gencell Pharma to expand single-cell sequencing solutions in South America, enhancing research capabilities.
Glenmark Pharmaceuticals recalls 114 batches of 750mg potassium chloride capsules due to dissolution issues, posing hyperkalemia risks.
CSPC Pharmaceutical Group advances with China's approval for mRNA-based cancer cell therapy trial, setting new standards in medical innovation.
CatSci Ltd acquires Reach Separations, enhancing chromatography services from discovery to manufacturing with support from Keensight Capital.
Discover Thermo Fisher's IntelliStack Incubator & CO2 Incubator Shakers—revolutionizing growth environments with precision and reliability for life sciences.
Haelium pioneers pharmaceutical innovation with high-purity solutions and advanced drug delivery products, ensuring global health advancements.
Haleon divests Nicotinell business to Dr. Reddy's, enhancing strategic focus while expanding consumer healthcare capabilities globally.
FDA approves Verona Pharma's Ohtuvayre for COPD. First non-steroidal inhaled treatment, boosting lung function.
Bora Pharmaceuticals acquires Emergent BioSolutions' Camden facility, boosting U.S. presence and sterile manufacturing capabilities.
Nxera Pharma hits a $10M milestone in neurological disease R&D with AbbVie, advancing novel GPCR targets. Potential $1.2B in milestones ahead!
Read how Rhenopharma Group enhances its global pharmaceutical services with the acquisition of Konapharma AG, a leading Swiss contract manufacturer.
Veranova invests $30M to expand its Devens facility, enhancing capabilities in ADC and potent compound development to meet growing US demand.
Jagsonpal acquires Yash Pharma, expanding into dermatology and pediatrics, enhancing market position.
Stay updated on CDSCO's risk-based inspections and new initiatives to enhance drug quality in India's pharmaceutical industry.
Aurobindo Pharma announces US inspection results, partnership with Merck Sharp & Dohme, and strong Q4 FY24 financial performance.
Rocket Pharmaceuticals' shares drop 12% as FDA delays approval of their gene therapy for a rare pediatric disorder, seeking more process information.
Lupin Ltd acquires Gavis Pharmaceuticals LLC and Novel Laboratories Inc. for $880 million, enhancing US market presence with expanded generics pipeline.
Alembic Pharmaceuticals' latest FDA-approved Doxycycline Capsules, 40 mg, for treating rosacea, propel stock surge and market growth.
A milestone in Wockhardt’s clinical trials as Zaynich, an investigational drug, effectively treated a young cancer patient with compromised immunity in the US.
Discover Alembic Pharmaceuticals' latest achievement as their Gujarat oncology facility secures US FDA's Establishment Inspection Report (EIR).
Discover Eisai's new dementia treatment targeting tau protein, aiming for U.S. launch by 2030. Leqembi also set for China debut.
A judge dismissed cancer victims' bid to block Johnson & Johnson's $6.48B talc settlement, stating potential harm was hypothetical. Voting deadline is July 26.
Biogen secures Tecfidera patents after U.S. board rules in its favor, ending royalty dispute with Forward Pharma, impacting stock prices.
President Bola Ahmed Tinubu signs Executive Order to reduce drug prices in Nigeria, eliminating tariffs and VAT on healthcare equipment and raw materials.
ARS Pharma's needle-free nasal spray, EURneffy, gets EMA's nod. Awaiting FDA approval by October 2. Positive results and advocacy groups' support add momentum.
Regeneron Pharma receives CHMP's positive opinion for odronextamab, targeting relapsed/refractory follicular & diffuse large B-cell lymphomas in Europe.
Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib Tablets, used to treat chronic myelogenous leukemia. Market size estimated at US$ 275M.
Kanvas Biosciences, a full-stack spatial biology company, has raised $12.5 million in additional funding. This brings Kanvas's total funding to $29.5 million.
AstraZeneca has announced that the EU drug regulator has accepted a market authorisation app for Sipavibart, under an accelerated assessment.
With the Union Budget 2024 approaching, the pharma industry is hoping to get better incentives for R&D and grow market size to $120-$130 billion.
Cassava Sciences, a Texas-based pharmaceutical company, will form a committee to evaluate new probes by U.S. regulators and investigate two senior employees.
TauRx Pharma has applied to the UK Medicines and Healthcare Products Regulatory Agency for approval of hydromethylthionine mesylate to treat Alzheimer's disease
Alcon acquires BELKIN Vision for $81M, enhancing glaucoma treatment with DSLT technology, aiming for US market entry.
MBK Partners to acquire Japan's Alinamin Pharmaceutical for 350B yen, boosting its presence in the Asian pharma market.
Media partnership announcement between Pharma Now and the Indian Pharmaceutical Congress for the IPC Expo in Hyderabad.
Pharma Now announces its media partnership with the 14th National Exhibition, Asia Labex 2024 in Gandhinagar.
Semnur Pharma to go public via $2B merger with SPAC, focusing on non-opioid pain treatment SP-102 for sciatica.
Samsung Biologics inks $1.06B deal with unnamed U.S. pharma, boosting manufacturing amid BIOSECURE Act concerns.
Eli Lilly partners with Radionetics Oncology for $140M, with a $1B acquisition option to advance radiopharmaceuticals.
Codexis sells investigational compounds for Fabry and Pompe diseases to Crosswalk Therapeutics, securing milestone payments.
Legal battle over Covid-19 vaccine patents: Moderna wins partial victory against Pfizer and BioNTech in UK court.
GSK leads on new mRNA flu and COVID vaccines with CureVac, gaining full control; CureVac receives €400M upfront plus milestones.
Pharma Now partners with the Digital Transformation in Life Science R&D Conference. Don't miss this pivotal event!
Radionetics Oncology partners with Eli Lilly to develop GPCR-targeted radiopharmaceuticals for treating solid tumors.
Mankind Pharma aims to acquire Bharat Vaccines and Serums for $1.7-$2B, enhancing its market presence in critical healthcare.
Sun Pharma acquires 85.1% of JSC Biosintez for $24M to boost its Russian market presence with local manufacturing.
"SIRTURO® achieves FDA and EC full approvals for MDR-TB, marking a pivotal advancement in TB treatment."
Aurigene partners with Edity Therapeutics to provide discovery services for cell therapy, boosting clinical development in oncology, gene therapy, and more.
Herantis Pharma tests HER-096 for safety in Parkinson’s, aiming to protect and restore dopamine-producing brain cells.
Philogen and Sun Pharma's Nidlegy™ MAA validated by EMA, aims to treat locally advanced, resectable melanoma.
Viatris sold its OTC business to Cooper Consumer Health, finalizing a $3.37B divestiture plan to refocus and reinvest.
AstraZeneca to invest Rs 250 crore in Chennai, creating 1,300 jobs and expanding its Global Innovation and Technology Centre.
Torque Pharma wins "Best Healthcare Brand of 2024" by ET Edge, launches 'Better Together' rebranding for global expansion.
Aluflexpack launches 4∞ Form, a fully recyclable aluminium blister pack for the pharmaceutical industry, reducing waste.
Direct Pharma Logistics expands into Bulgaria with Medex, plans Moldova entry, aiming for 50M euros turnover, says Forbes.ro.
AstraZeneca's Tagrisso, approved by the EU, combines with chemotherapy for first-line NSCLC treatment in adults with EGFR mutations, improving survival rates.
Federal judge dismisses Boehringer Ingelheim's challenge to Medicare drug price negotiation, dealing a blow to pharma's legal stance.